NCT03090854View on ClinicalTrials.gov

Cholinergic Markers Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

January 12, 2021

Study Completion Date

January 12, 2021

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

ADASCog

Neuropsychological test

Trial Locations (1)

75010

Centre Mémoire de Ressources et de Recherche Paris Nord, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03090854 - Cholinergic Markers Alzheimer's Disease | Biotech Hunter | Biotech Hunter